Which has grown faster, CCCC or LAB?

Over the past five years, CCCC grew revenue faster — CCCC at a 0.65% CAGR versus LAB at -10.62%.

How have CCCC and LAB total returns compared?

Over the past 5 years, CCCC delivered -41.77% and LAB delivered -32.98% annualized total return. Past performance doesn't predict future results.

C4 Therapeutics, Inc. (CCCC) vs Standard BioTools Inc. (LAB)

A side-by-side comparison of C4 Therapeutics, Inc. and Standard BioTools Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CCCC

C4 Therapeutics, Inc.

$318M

$2.88HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

LAB

Standard BioTools Inc.

$283M

$0.72HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CCCC vs LAB

growth of $100 · dividends reinvested · last 6y

CCCC -88.3% (-30.0%/yr)LAB -90.1% (-31.9%/yr)CCCC compounded faster over this window

CCCC LAB

CCCC vs LAB: by the numbers

•CCCC is the larger company ($318M vs $283M market cap).
•Both run net losses; LAB's is the smaller (-103.29% vs -289.44% net margin).
•CCCC grew revenue faster over the past five years (0.65% vs -10.62% CAGR).

Metrics side by side

Valuation

Metric	CCCC	LAB
P/S ratio	9.09	3.34
P/B ratio	1.29	0.52

Profitability

Metric	CCCC	LAB
Gross margin	77.81%	49.14%
Operating margin	-290.68%	-109.34%
Net margin	-289.44%	-103.29%
ROE	-41.02%	-16.18%
ROIC	-35.92%	-14.06%

Growth (annualized)

Metric	CCCC	LAB
Revenue CAGR (5Y)	0.65%	-10.62%
Total return CAGR (5Y)	-41.77%	-32.98%

Frequently asked

Which has grown faster, CCCC or LAB?: Over the past five years, CCCC grew revenue faster — CCCC at a 0.65% CAGR versus LAB at -10.62%.
How have CCCC and LAB total returns compared?: Over the past 5 years, CCCC delivered -41.77% and LAB delivered -32.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CCCC analysis Full LAB analysis Interactive comparison tool

Dig into the metrics

C4 Therapeutics ROE Standard BioTools ROE C4 Therapeutics operating margin Standard BioTools operating margin C4 Therapeutics revenue growth Standard BioTools revenue growth C4 Therapeutics free cash flow Standard BioTools free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.